| Highly parallel profiling of Cas9 variant specificity JL Schmid-Burgk*, L Gao*, D Li*, Z Gardner, J Strecker, B Lash, F Zhang Molecular cell 78 (4), 794-800. e8, 2020 | 156 | 2020 |
| LAMP-Seq: population-Scale COVID-19 diagnostics using a compressed barcode space. bioRxiv. 2020 J Schmid-Burgk, D Li, D Feldman, M Slabicki, J Borrajo, J Strecker, ... Google Scholar, 2020 | 96* | 2020 |
| LAMP-Seq enables sensitive, multiplexed COVID-19 diagnostics using molecular barcoding KU Ludwig, RM Schmithausen, D Li, ML Jacobs, R Hollstein, ... Nature biotechnology 39 (12), 1556-1562, 2021 | 55 | 2021 |
| RNA-activated protein cleavage with a CRISPR-associated endopeptidase J Strecker*, FE Demircioglu*, D Li, G Faure, ME Wilkinson, JS Gootenberg, ... Science, eadd7450, 2022 | 35 | 2022 |
| Disease-specific tau filaments assemble via polymorphic intermediates S Lövestam, D Li, JL Wagstaff, A Kotecha, D Kimanius, SH McLaughlin, ... Nature 625 (7993), 119-125, 2024 | 20 | 2024 |
| A CRISPR-based assay for the study of eukaryotic DNA repair onboard the International Space Station S Stahl-Rommel, D Li*, M Sung*, R Li*, A Vijayakumar*, KD Atabay*, ... Plos one 16 (6), e0253403, 2021 | 14 | 2021 |
| Modularity and diversity of target selectors in Tn7 transposons G Faure, M Saito, S Benler, I Peng, YI Wolf, J Strecker, H Altae-Tran, ... Molecular cell 83 (12), 2122-2136. e10, 2023 | 7 | 2023 |
| Novel cas enzymes and methods of profiling specificity and activity F Zhang, JL Schmid-Burgk, L Gao, D Li EP Patent App. EP4118203A1, 2023 | 1 | 2023 |
| Helitron mediated genetic modification F Zhang, J Strecker, D Li US Patent App. 18/248,199, 2023 | | 2023 |
| Sequencing-based population scale screening F Zhang, J Schmid-Burgk, D Li US Patent App. 17/916,087, 2023 | | 2023 |
| Genome editing using reverse transcriptase enabled and fully active crispr complexes F Zhang, J Strecker, D Li US Patent App. 17/786,168, 2023 | | 2023 |
